FEATURED PRODUCTS

• A Complete Portfolio Of Cell Lines Designed For AAV Production

  Discover how you can enhance your gene therapy efforts with a comprehensive range of cell lines designed for adeno-associated virus (AAV) production.

• An Off-The-Shelf Transient Cell Line For Viral Vector Production

  Discover an off-the-shelf transient cell line engineered for speed and simplicity, enabling seamless integration into existing researchers' and technicians' workflows.

• ELEVECTA™ Producer Cell Line For Stable, Inducible AAV Production

  ELEVECTA™ producer cell line is a stable line for inducible adeno-associated virus (AAV) production. It is a true producer cell line that has Rep, Helper, Cap, and gene of interest (GOI) stably integrated into the host cell’s genome, and it requires only a single induction step to initiate AAV production.

• A Cell Therapy Manufacturing Platform Made To Automate Key Steps

  The Sefia™ cell therapy manufacturing platform is made up of two digitally integrated and functionally closed systems that automate key manufacturing steps. 

• A Platform To Transform Cell Therapy Manufacturing

  Explore this end-to-end cell therapy solution transforming cell therapy manufacturing and helping you deliver what’s next in CAR T manufacturing, from starting sample to final doses.

• A Comprehensive Upstream Platform For Gene Therapy Applications

  Explore a variety of cell lines, high-performance cell culture media, and single-use bioreactors to suit your process needs for any cell type.

• Comprehensive Solution For Autologous Cell Therapy Manufacturing

  Explore detailed information regarding a comprehensive solution for cell therapy manufacturing that consists of two hardware components, specialized application software, and single-use kits.

• An Inside Look At Cell Therapy Services And Support

  “Services” and “support.” What do those words mean in the life science manufacturing industry? The truth is, they’re quite subjective—and relative to each company. Here’s how we define services and support at Cytiva.

• Producer Cell Line To Elevate Your AAV Production To The Next Level

  Discover a true producer cell line where Rep, Helper, Cap, and the gene of interest are stably integrated into the host cell's genome, requiring only a single induction step to initiate AAV production.

• A Stable Cell Line For Inducible AAV Production

  Delivering on the promise of AAV-based gene therapies beyond rare diseases will require large quantities of high-quality AAV, produced in a robust manner.

• AAV Manufacturing Workflow

  Explore scalable and flexible single-use solutions from design to delivery that can help you overcome challenges throughout adeno-associated virus (AAV) manufacturing workflow.

• Single-Use System For Clinical And Commercial Production Of LNPs

  Learn about a scalable, single-use platform with built-in automation and regulatory compliance that enables standardized manufacturing workflows for mRNA-LNP drug product production.

• Automated, Single-Use System For Clinical And Commercial LNP Production

  The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.

• Services For Advancing mRNA-LNPs From Bench To Clinic

  Discover a one-stop-shop for LNP technologies that provides access to expertise in formulation and analytics for successful outcomes for payload and target applications. Explore end-to-end biopharma services and systems.

• Biopharmaceutical Services

  Combining disruptive technology platforms with unparalleled genomic medicine development expertise, Precision NanoSystems’ Biopharmaceutical Services accelerates the development of lipid nanoparticle (LNP) formulations and drug products.

• A Disruptive Technology Accelerating Drug Development

  Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical development.

   

• GenVoy-ILM™ T Cell Kit For mRNA, Ignite™

  GenVoy-ILM™ T Cell Kit for mRNA, Ignite is an lipid nanoparticle (LNP) reagent mix optimized for the delivery of messenger RNA (mRNA) or Cas9 mRNA/sgRNA into activated human primary T cells.

• A Next-Generation Technology For The Power To Scale

  With NxGen™ technology on the NanoAssemblr^® Blaze™, important studies can be conducted efficiently with a process that mirrors a clinical scale implementation.

• T Cell Kit For mRNA On NanoAssemblr Spark

  The GenVoy-ILM T Cell Kit for mRNA is optimized for the delivery of mRNA into activated primary human T cells using mRNA-LNPs formulated on the NanoAssemblr Spark instrument and cartridges.

• NanoAssemblr® GMP System: Power To Commercialize

  Built on our revolutionary NxGen™ technology found in our NanoAssemblr^® family of instruments, the NanoAssemblr^® GMP System enables you to go from concept to clinic with speed and confidence.